iBio (IBIO) Enterprise Value (2016 - 2025)
Historic Enterprise Value for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to -$52.7 million.
- iBio's Enterprise Value fell 65161.8% to -$52.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$52.7 million, marking a year-over-year decrease of 65161.8%. This contributed to the annual value of -$8.6 million for FY2025, which is 3960.59% up from last year.
- As of Q4 2025, iBio's Enterprise Value stood at -$52.7 million, which was down 65161.8% from -$49.6 million recorded in Q3 2025.
- In the past 5 years, iBio's Enterprise Value registered a high of -$3.8 million during Q4 2023, and its lowest value of -$97.0 million during Q2 2021.
- In the last 5 years, iBio's Enterprise Value had a median value of -$12.6 million in 2024 and averaged -$30.4 million.
- As far as peak fluctuations go, iBio's Enterprise Value crashed by 74229.28% in 2021, and later skyrocketed by 8649.24% in 2023.
- iBio's Enterprise Value (Quarter) stood at -$57.4 million in 2021, then surged by 83.22% to -$9.6 million in 2022, then skyrocketed by 60.05% to -$3.8 million in 2023, then crashed by 82.44% to -$7.0 million in 2024, then plummeted by 651.62% to -$52.7 million in 2025.
- Its Enterprise Value stands at -$52.7 million for Q4 2025, versus -$49.6 million for Q3 2025 and -$8.6 million for Q2 2025.